Table 4. Correlation between different response and the PFS in whole series of NSCLC patients (n = 59).
| Items | PFS (months) (95% CI) | Univariate analysis P* | Median survival (months) (95% CI) | Univariate analysis P* |
|---|---|---|---|---|
| 1. PR | 7.4(3.7–11.0) | 0.847 | 27.8(15.7–39.9) | 0.747 |
| SD | 6.9(6.4–7.4) | 24.1(13.2–35.1) | ||
| 2. PR + SD | 7.3(6.1–8.4) | <0.001 | 27.8(20.0–35.6) | 0.001 |
| PD | 1.5(0.6–2.5) | 10.6(0.3–21.0) | ||
| 3. SD | 6.9(6.4–7.4) | <0.001 | 24.1(13.1–35.2) | 0.018 |
| PD | 1.5(0.6–2.5) | 10.6(0.3–21.0) | ||
| 4. PR | 7.4(3.7–11.0) | <0.001 | 27.8(15.7–39.9) | 0.002 |
| PD | 1.5(0.6–2.5) | 10.6( 0.3–21.0) |
Note:*Log-Rank test.
Abbreviations: CI, Confidence interval; OS, overall survival; PFS, progression free survival; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease.